this protocol describes an eDta-based passaging procedure to be used with chemically defined e8 medium that serves as a tool for basic and translational research into human pluripotent stem cells (pscs). In this protocol, passaging one six-well or 10-cm plate of cells takes about 6-7 min. this enzyme-free protocol achieves maximum cell survival without enzyme neutralization, centrifugation or drug treatment. It also allows for higher throughput, requires minimal material and limits contamination. Here we describe how to produce a consistent e8 medium for routine maintenance and reprogramming and how to incorporate the eDtabased passaging procedure into human induced psc (ipsc) derivation, colony expansion, cryopreservation and teratoma formation. this protocol has been successful in routine cell expansion, and efficient for expanding large-volume cultures or a large number of cells with preferential dissociation of pscs. effective for all culture stages, this procedure provides a consistent and universal approach to passaging human pscs in e8 medium.
IntroDuctIon
The study of human embryonic stem cells (ESCs), the first established human PSC lines 1, 2 , led to the derivation of iPSCs from human somatic cells [3] [4] [5] . Human ESCs and iPSCs are both capable of generating cells from all three germ lines, and have thus gathered tremendous interest for their practical and scientific values. Maintained in cell culture, both are affected by different culture conditions and cell handling techniques.
Cell culture conditions for human ESCs and iPSCs have evolved from feeder-dependent and feeder-free medium to defined medium on defined extracellular matrix (ECM) 1, 2, [6] [7] [8] [9] . Improved understanding of self-renewal and differentiation means that growth media and ECM are becoming increasingly defined and simplified. At the same time, multiple cell handling techniques have evolved to facilitate PSC research. However, no single technique can be used at every stage of culture, from expansion through differentiation and cryopreservation.
Dissociation of ESCs
For regular cell culture practices, cells are often individualized during passaging to achieve even distribution and uniform treatments. However, human ESCs survive poorly after individualization (i.e., being made single cell), because these cells are more sensitive to treatments and are prone to cell death, a fact that has made the development of a universal dissociation method particularly challenging. In routine experiments, dissociation methods are chosen on the basis of either cell survival or sensitivity. In regular expansion, cell survival is the priority. ESCs and iPSCs are usually passaged as aggregates with enzymatic dissociation, with collagenase used for culture on feeder cells 1, 2 and Dispase used for culture on feederfree cells 8 . Mechanical approaches, such as cell scrapers and other passaging tools, have also been developed to dissociate cells as aggregates. Furthermore, in a differentiation or transfection experiment, TrypLE and Accutase can be used to individualize ESCs, but poor survival often leads to abnormal karyotypes [10] [11] [12] ; small chemicals, such as Rho-associated protein kinase (ROCK) inhibitors, must be used to boost cell survival in this process 13 . All these methods require specialized tools or reagents that are costly for long-term or large-scale experiments. At the same time, the consistency of enzymatic methods is usually affected by the quality of enzymes from batch to batch. Given the variability of these methods, it is highly desirable to find a universal approach for all purposes.
The quality of culture conditions is also crucial to the maintenance and expansion of PSCs. The medium components related to feeder cells or animal products often greatly affect the consistency of the cell culture, which could be even more problematic when cells have potential applications in translational research. To improve the consistency of cell culture, we systematically analyzed the functions of individual medium components, and finally formulated a xeno-free, chemically defined stem cell medium E8, which contains eight essential factors for human ESCs 14 . With minimal modification of E8, human iPSCs can be directly derived from skin biopsies in chemically defined conditions. This culture system could have great applications in future PSC research. In combination with the development of cell culture medium, a consistent xeno-free dissociation method is important to fulfilling the potential of the defined culture conditions.
We previously studied cell death mechanisms after individualization and found that myosin-actin-dependent contraction leads to cell death, and that cell-cell adhesions promote survival by inhibiting the contraction 15 . Cells survived by reforming small aggregates Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions in the first few hours after dissociation. This observation provided the theoretical foundation for a method that generates aggregates strong enough to survive, but small enough to be accessed by growth factors or transfection reagents. In combination with the development of chemically defined cell culture, we set out to devise a universal dissociation technique for the expansion, cryopreservation, and experimentation of human PSCs in defined conditions. We found that, after a specific EDTA treatment, cells can be partially dissociated to generate small aggregates that survive as well as Dispase-treated cells, and which are more accessible to various treatments. When used with the chemically defined E8 medium, this dissociation method can be used to handle human PSCs during derivation, expansion and preservation. In this protocol, we describe how to derive iPSCs from fibroblasts as an example of how to use our EDTA dissociation method and defined chemical culture conditions in each stage of the iPSC derivation process.
Development of the protocol
Conventionally, human PSCs are passaged as aggregates with enzymes, with individualized cells typically dying from actomyosin contraction. However, individualized cells can survive through the inhibition of ROCK-actin-myosin pathway components. Alternatively, cells can survive naturally through reaggregation of adjacent cells, indicating that higher local density could lead to reassociation efficiency independent of drug treatment (Fig. 1a) . We found that EDTA treatment could partially dissociate human ESCs, and that ESCs were easily washed off with medium ( Supplementary Fig. 1a) . Loose adhesions between the cells generated very high local density beneficial to cell survival. Most cells were in small aggregates, which attached to a Matrigel-coated plate within minutes (5 min), spread in 2 h and survived as colonies (24 h; Fig. 1b) . EDTA-dissociated ESCs survive significantly better than individualized cells by TrypLE, and the survival efficiency is similar to passaging cells as large aggregates using a Dispase protocol ( Fig. 1c and Supplementary Methods) . Cell survival when using this EDTA method is comparable to that observed in cells treated by ROCK inhibitors (Supplementary Fig. 1b) , and it is E-cadherin dependent (Supplementary Fig. 1c ). This indicates that cells harvested by EDTA survive without drug treatment, but require direct cell-cell adhesion.
Because of the survival efficiency of EDTA dissociation, we have used it extensively in long-term culture expansion of human PSCs, on more than 50 different human ESCs and iPSCs in different feeder-free media, including TeSR and E8. In each of these cases, normal karyotypes were effectively maintained in long-term culture. The longest iPSC culture conducted in our research lasted more than 51 passages and longer than 6 months, and the cells maintained normal karyotypes (Supplementary Table 1 lists some of these ESC and iPSC lines). Cells dissociated by EDTA efficiently survived not only on Matrigel and vitronectin surfaces, but also on synthetic surface independent of ROCK inhibitors (Supplementary Fig. 1d ). Because of its simplicity and consistency, this protocol has been used for our routine cell culture practices [14] [15] [16] [17] , and other groups have successfully used EDTA dissociation to maintain human PSCs 18 .
EDTA dissociation is also useful in transfection and differentiation experiments ( Supplementary Fig. 2 and Supplementary Methods). In transfection experiments, EDTA-dissociated cells were transfected efficiently while maintaining high survival rate ( Supplementary Fig. 2a-c) . At the same time, these cells were sensitive to growth factor-induced differentiation ( Supplementary  Fig. 2d ). We hypothesize that EDTA dissociation enables small aggregates to survive better than individualized cells, and that the use of this method allows easier access to reagents used in differentiation experiments when compared with conventional aggregates collected with enzymes such as Dispase. The EDTA method can also be used to harvest PSCs for effective teratoma formation in immune-deficient mice. EDTA dissociation has been successfully used for all culture stages of human PSCs.
EDTA dissociation also improves the handling of Fig. 3a,b) . In comparison, TrypLE ubiquitously dissociates both ESCs and fibroblasts. These observations led us to use EDTA dissociation for iPSC derivation and colony expansion, which requires both human PSCs and somatic cells. In a conventional iPSC derivation procedure, cells are often passaged as individual cells, with ROCK inhibitors boosting iPSC survival before individual colonies are picked. However, we have used EDTA differential dissociation and harvested iPSCs with high survival rates without the help of a ROCK inhibitor ( Supplementary Fig. 3c ); we found that most EDTA-dissociated cells expressed the stem cell marker SSEA-4 ( Supplementary Fig. 3d ). EDTA dissociation thus enables the enrichment of potential iPSCs in an overcrowded reprogramming culture in which a secondary passaging is needed. We have also used EDTA dissociation to expand isolated iPSC colonies. We have often left differentiated cells in the original plate and found that stem cells reached a high purity in one or two passages. In addition, in EDTA-based cell expansion, we have routinely maintained established ESC and iPSC lines with high purity (i.e., >95% of the population is positive for the stem cell marker OCT4) without enrichment by manual picking. It is possible that spontaneous differentiation is suppressed by the easy access to growth factors by small aggregates created by EDTA passaging, and that differential dissociation allows potential enrichment of stem cells after each passage while leaving some differentiated cells behind.
In addition to preferential dissociation, EDTA passaging has another advantage: it is a quick procedure with minimal opportunity for contamination. The procedure can be performed in a biosafety cabinet, and it does not require enzymatic neutralization and centrifugation. We are thus able to passage 24 individual lines in 15 min with minimal risk of contamination. In addition, as EDTA treatment does not damage the ECM, a portion of the iPSCs can be maintained in the original wells after dissociation, providing a backup or duplicate plate for maintenance or further characterizations.
Experimental design E8 medium production. This protocol describes how to produce chemically defined stem cell medium E8 with the formulas listed in Tables 1 and 2 . To maintain consistency in the cell culture, Table 2 ). Full E8 medium can be prepared with additional self-renewal essential factors ( Table 2 ). The medium can also be prepared on a small scale with the reagents listed in Tables 1 and 2 .
Routine cell culture expansion with EDTA dissociation. When the E8 medium is ready, we test it with H1 ESCs and one control fibroblast iPSC line. EDTA dissociation is used to passage the cells for at least five passages, and cells are then analyzed with flow cytometry and karyotyping. After the E8 medium passes the test, the frozen stock can be used for routine cell culture expansion and other experiments. We find that OCT4-positive cells consistently compose >95% of the population when we use the EDTA passaging method with E8 medium.
Derivation of human iPSCs from fibroblast cells. After E8 components pass the quality test, a set of E8-based media are used to reprogram human skin fibroblast cells. After transduction, cells are first cultured in E8-based reprogramming medium 1 and then in reprogramming medium 2 ( Table 2) . We usually perform the reprogramming experiment in a six-well plate so that multiple treatments can be applied to the cells in the same experiment (Fig. 2) . Sodium butyrate treatment is usually used to improve reprogramming efficiency. Reprogramming cells usually show up about 3-5 d after transduction, and the colonies mature 20-30 d after transduction.
During this period, cells usually need to be passaged to avoid overconfluence, which can inhibit the emergence of true iPSC colonies. The EDTA method is applied to dissociate cells after the emergence of reprogramming cells, which preferentially enrich potential iPSCs.
The procedure has been successfully used in lentiviral-, Sendai virus-and episomal DNA-based reprogramming. For simplicity, we used commercially available STEMCCA polycistron lentivirus in this protocol. This procedure could also be modified to reprogram human umbilical vein endothelial cells (HUVECs) and adipocyte cells.
Colony expansion and preservation of human iPSCs. When iPSCs are mature, individual colonies are mechanically isolated into a 24-well plate for colony expansion. Cells are subsequently expanded with the EDTA method, and can then be cryopreserved in 3-5 d. The cells can be expanded and should be characterized by alkaline phosphatase staining (APS) and other appropriate characterizations. After further confirmation by karyotyping and immunostaining for pluripotency markers, validated iPSC lines can be used for teratoma formation with the EDTA method. • Holo-transferrin (1,000×) Dissolve 500 mg of Holo-transferrin in 50 ml of Dulbecco's PBS and filter to sterilize. This makes a 1,000× (10 mg ml − 1 ) stock that can be divided into 500-µl aliquots and frozen at − 80 °C, at which temperature it is stable for at least 1 year.
FGF (1,000×)
One milligram of FGF should be dissolved in 10 ml of sterile 0.05% HSA in PBS. This 1,000× FGF (0.1 mg ml − 1 ) should be divided into 500-µl aliquots and frozen at − 80 °C, at which temperature it is stable for at least 1 year. TGF-b1 (1,000×) TGFβ1 should be resuspended to a concentration of 1.74 µg ml − 1 (1,000×) in sterile 0.05% HSA in 4 mM HCl in PBS. This is then aliquotted into 500-µl aliquots and frozen at − 80 °C; it is stable at this temperature for at least 1 year. Hydrocortisone (10,000×) A measure of 3.625 mg of hydrocortisone is dissolved in 1 ml of sterile water (10 mM stock). This solution is then divided into 50-µl aliquots and frozen at − 80 °C; it is stable at this temperature for at least 1 year. Sodium butyrate (1,000×) A measure of 110 mg of sodium butyrate is dissolved in 10 ml of sterile water and filtered (100 mM stock). This is then divided into 500-µl aliquots and frozen at − 80 °C; it is stable at this temperature for at least 1 year. Cryopreservation medium (2×) Add 2 ml of sterile DMSO and 20 µl of 10 mM ROCK inhibitor stock into 8 ml of E8 medium to make 2× cryopreservation medium for iPSCs in colony expansion. Medium can be stored at 4 °C for up to 1 week. Polybrene stock (1,000×) Dissolve the polybrene in PBS to 1,000× (6 µg ml − 1 ) and filter to sterilize. Freeze the solution in small aliquots at -80 °C and store them for up to 1 year before use. The final concentration on cells during infection will be 6 ng ml − 1 . E8 base medium Pour 50 liters of DMEM-F12 medium into a suitable container, and stir it on a stir plate. Save the empty bottles. Add 3,200 mg of l-ascorbic acid and 970 µl of sodium selenite (0.7 mg ml − 1 stock) into the medium and mix well. Adjust the pH to 7.4 with 10 N NaOH. Add NaCl to adjust the osmolarity to 340 mOsm. Aliquot the medium back into the original bottles. The final composition of the medium should contain 64 mg l − 1 l-ascorbic acid and 13.6 µg l − 1 sodium selenite. The details of how to make this medium are also given in Table 1 . This base E8 medium should be frozen and stored at − 20 °C; it is stable at this temperature for at least 1 year. Full E8 (TGF-b1) medium Thaw one bottle (500 ml) of E8 base medium. Add 500 µl of 1,000× holo-transferrin, 500 µl of 1,000× FGF, 500 µl of 1,000× TGF-β1 and 1 ml of 10 mg ml − 1 insulin. Filter the E8 (TGF-β1) medium through a 500-ml Millipore Stericup filter. Store the medium at 4 °C before use. The medium is stable for 2-3 weeks at 4 °C. Do not warm this medium in a 37 °C water bath before use, as it will shorten the life of the growth factors. Note that full E8 medium can now be purchased as Essential 8 medium from Life Technologies (cat. no. A14666SA) or from Stem Cell Technologies (cat. no. 05840) as TeSR-E8. The details of how to make this medium are also given in Table 2 . ! cautIon These purchased media are only for stem cell maintenance. They contain TGF-β1, which can interfere with reprogramming. Reprogramming media 1 and 2 Prepare 500 ml of reprogramming medium with the same formula as Full E8 medium, but leave out the TGF-β1. In place of the TGF-β1, either add 50 µl of 10,000× hydrocortisone (reprogramming medium 1) or 500 µl of 1,000× sodium butyrate (reprogramming medium 2) before filtering. The details of how to make these media are also given in Table 2 . Media can be stored at 4 °C for up to 2 weeks.
proceDure Human psc expansion with eDta in full e8 medium (tGF-b1 medium) • tIMInG 6-7 min per plate 1| Place a new six-well plate that has been coated with Matrigel (box 1) and warmed to room temperature (RT, 20-25 °C) in the tissue culture hood. In addition, keep the EDTA solution ready, which has been warmed to RT.
2|
Label the new Matrigel-coated plate and aspirate the Matrigel from the well. Replace it with 1.5-2 ml of full E8 medium (or E8 medium + ROCK inhibitor if desired) per well.  crItIcal step This step can also be performed during the EDTA incubation, but if a large number of cells are being passaged it is better to prepare plates ahead, as time is limited.
3|
Aspirate the medium from the ESCs or iPSCs that are about to split. Rinse the wells with 1 ml per well of EDTA solution to remove the magnesium and calcium from the medium.  crItIcal step When rinsing, add the EDTA solution to the wells and then immediately aspirate the EDTA again without incubating.  crItIcal step When washing with EDTA, add the EDTA to the wall of the well slowly to avoid washing the colonies off the plate too early.
4|
Repeat the EDTA wash (as described in Step 3) a second time to ensure that all magnesium and calcium is removed. Add another 1 ml per well of the EDTA solution and let it sit for 2-5 min at RT within the hood.  crItIcal step The longer the cells sit in the EDTA, the smaller the colonies that will result. In addition, it is important to keep the movement of the plate to a minimum in order to avoid lifting the colonies completely off the plate during this step.
5| After 2-5 min, carefully aspirate the EDTA solution from the cells. Use 1-4 ml of E8 medium (or E8 medium + ROCK inhibitor) and add it rapidly to wash the colonies off the plate and disperse the colonies as quickly as possible. The calcium and magnesium in the medium will neutralize any remaining EDTA.  crItIcal step Do not break apart the colonies too much by excess pipetting.  crItIcal step This and the next step should be performed quickly, as the colonies start to reattach to the plate very rapidly after the addition of calcium and magnesium.
? troublesHootInG 6| Ensure that the cell suspension is well mixed. and then plate the desired cell amount per well in the newly prepared plate.
7| Shake the plate back and forth and side to side to distribute the cells. Place the plate in an incubator. Let it sit overnight for maximum attachment.
Box 1 | Matrigel preparation
1. At least 1 d before the experiment, put one bottle of Matrigel on ice, in a 4 °C refrigerator, or in a cold room overnight. At this time, also place 2-ml microcentrifuge tubes in the refrigerator to chill. 2. Aliquot 2 mg of Matrigel into each prechilled 2-ml microcentrifuge tube, and immediately freeze it. Matrigel concentration is usually 7-10 mg ml − 1 . Check the exact concentration on the product sheet. Two milligrams of Matrigel will be used to coat two six-well plates.
Half the amount of Matrigel also works for routine culture.  crItIcal step While making aliquots, it is important that everything stay cold in order to prevent the Matrigel from hardening. Matrigel aliquots should be stored at − 80 °C and are stable for at least 1 year. 3. Pour 12 ml of cold DMEM-F12 in a conical tube, and use 1.5 ml of this medium to thaw and resuspend each Matrigel aliquot with a 5-ml pipette.  crItIcal step Matrigel should be removed from the freezer right before the experiment, and should still be frozen when the 1.5 ml of medium is added. 4. Take the thawed and resuspended Matrigel and return it to the rest of the 12 ml of DMEM-F12. Rinse the Matrigel tube again with the same medium. 5. Mix the Matrigel well, plate 1 ml into each well of two six-well plates, and shake the plate well to cover the entire surface. 6. Leave the plate at RT or at 37 °C for at least 30 min, or coat it overnight at 4 °C.
HSA in PBS Add 25 mg HSA to 50 ml of 4mM PBS and filter to sterilize. Store it for 1-2 months at 4 °C or make aliquots and store them at -20 °C for 1 year. 8| On the next day, take the E8 medium out from a 4 °C refrigerator; let it sit at RT to warm, if desired. Remove the medium from cells, and add 2 ml of E8 medium to each well in the six-well plate.
HSA in HCl-PBS
? troublesHootInG 9| On each following day, repeat Step 8, monitor cells daily, and when confluence reaches ~80% repeat Steps 1-7 (usually between 3 and 5 d after seeding). Passage the cells for the desired number of passages. After five passages, we recommend collecting some cells for FACS to measure pluripotency markers and for karyotyping. If the FACS and karyotyping results are satisfactory, the medium components are suitable for iPSC maintenance and reprogramming. This enzyme-free passaging protocol can be used during the derivation of iPSCs from other cell types. When you are ready to begin reprogramming, continue to the next section.
? troublesHootInG transduction of human fibroblasts • tIMInG 3 d 10| Take a low-passage-number fibroblast culture and plate it in one well of a six-well dish so that cells will be about 80% confluent the next day (100,000 or 150,000 cells per well) in fibroblast medium (usually 10% (vol/vol) FBS, penicillinstreptomycin, l-glutamine and non-essential amino acids in DMEM; however, if your fibroblasts are growing in another medium, use that medium). Incubate the cells overnight.
11|
Late on the next day, mix together 1.5 ml of fibroblast medium with polybrene (to obtain 6 ng ml − 1 final concentration). Add Millipore STEMCCA virus at the desired titer, add the mixture to the cells, and leave on the cells overnight. Our current protocol uses a multiplicity of infection (MOI) of ~5-10. On the next day, if cells are nearly confluent, change the medium to fresh fibroblast medium to remove polybrene. Coat two six-well plates with Matrigel, as described in box 1.
culture of transduced fibroblasts on Matrigel • tIMInG 3-4 weeks 12| Still on the same day, passage the well of reprogramming cells using TrypLE. TrypLE dissociation preserves cells better than regular trypsin-EDTA, and it does not require serum-based neutralization. To do this, remove the medium from the cells and add 0.5 ml of TrypLE to the wells. Incubate for 5 min in an incubator, and then wash the cells off the plate with fibroblast medium into a centrifuge tube and dilute them fivefold with fibroblast medium to inactivate TrypLE.  crItIcal step Some cell lines do not come off the plate well with TrypLE. With these lines, you may want to wash the plate twice with EDTA before adding TrypLE.
13|
Spin cells down for 5 min at RT at 200g in a swinging bucket rotor and resuspend them in 24 ml of fibroblast medium. Remove the Matrigel/DMEM-F12 from the two six-well plates and add 2 ml of cells per well. This gives a final passage of one well of infected cells into two six-well plates coated with Matrigel in fibroblast medium or directly into reprogramming medium 1.
14|
Maintain the cells in reprogramming medium 1, replacing the medium every other day for 3-5 d.
15|
Remove the medium and replace it with reprogramming medium 2. To improve reprogramming efficiency, add 100 µM sodium butyrate into medium 2 on one plate.  crItIcal step The time at which to replace reprogramming medium 1 with 2 is based on cell confluence. Medium 1 acts to promote fibroblast growth, and should be switched to medium 2 when the confluence reaches ~20-30%. If cells are still very sparse, you may want to keep them in reprogramming medium 1 for a few more days.
16|
Continue replacing the medium every other day, using reprogramming medium 2 with or without sodium butyrate.
17|
Monitor the cells daily; if cells become too confluent while you are waiting for iPSC colonies to mature, the cells may need to be passaged with EDTA at some point during the 2 weeks. Choose three or four wells to passage with EDTA onto two new Matrigel-coated plates (1:3 ratio). Use the EDTA passaging method as described in Steps 1-7 above, but using reprogramming medium 2 instead of full E8 (TGF-β1) medium.
? troublesHootInG 18| Twenty to twenty-five days after transduction, colonies should be ready for picking. At this point, proceed to Step 19. Around this time, begin feeding the original reprogramming plates full E8 (TGF-β1) medium daily.
Mechanical isolation of human ipsc colonies • tIMInG 2-3 d 19|
For picking, prepare a 24-well plate by coating with Matrigel (as described in box 1, using 250 µl per well of the Matrigel stock for a total of 1 mg of Matrigel per 24-well plate).
20|
After the 30-min Matrigel incubation, replace Matrigel/DMEM-F12 with full E8 (TGF-β1) medium containing 1× ROCK inhibitor.  crItIcal step Although ROCK inhibitor is described as optional in the EDTA passaging method, ROCK inhibitor will greatly increase the survival chances of newly picked colonies.
21| Spray 70% (vol/vol) ethanol on a microscope and on the surrounding area, as well as on a pipette and a box of tips.  crItIcal step We pick the colonies on a benchtop in the laboratory using a normal inverted light microscope. If space allows, a microscope can be placed inside a laminar flow hood or a benchtop PCR clean hood to allow for a sterile field while picking colonies. If preferred, a dissection microscope can be used to find and manually passage the colonies.
22|
While wearing a facemask, find iPSC colonies under the microscope with the ×4 objective. By using a P20 pipette with a tip, circle around the colony until it is loosened from surrounding cells.
23|
While still using a pipette tip, cross-hatch the colony so that it will come off the plate in smaller pieces.
24|
Next, use the pipette to push the colony off the plate and suck it into a pipette tip. Transfer the colony pieces into one well of the 24-well plate.
25|
Repeat Steps 22-24 with other colonies, placing one colony in each well of the 24-well plate. Incubate the cells overnight in the tissue culture incubator.
26|
On the day after picking, remove the medium and replace it with full E8 (TGF-β1) medium without ROCK inhibitor. ? troublesHootInG
27|
Replace the E8 medium daily until the attached colony is big enough to passage. The colony is usually ready to passage after 2-3 d.
? troublesHootInG ongoing passage and analysis of colonies 28| When the colony is ready for passaging, use EDTA to passage as described in Steps 1-7. However, leave some of the cells in the original well of the 24-well plate while transferring most of them to a new Matrigel-coated well on a 12-or 6-well plate (again in 1× ROCK inhibitor). Continue to incubate the cells, replacing the medium daily and passing as described in  pause poInt Cells can be stored in liquid nitrogen for more than 5 years. (viii) To thaw cells, take the cryotube out of the liquid nitrogen tank and place it directly in a 37 °C water bath. Step 28A, cryopreservation, 6-10 min per line
Step 28B, APS staining: 1-2 h
Step 28C, teratoma formation: 6-9 weeks antIcIpateD results Chemically defined E8 medium provides ideal cell culture conditions for human PSC research. By modifying a few growth factors, we are able to create cell culture conditions for human iPSC derivation and expansion (tables 1 and 2). EDTA dissociation also provides a simple and efficient way to handle stem cells in different circumstances (table 4) . This combination of medium and handling method enables effective culture expansion and other treatments. All these experiments can be performed without drug treatment, but ROCK inhibitor is included in this protocol for those who prefer its use. When human fibroblasts are reprogrammed in the E8-based feeder-free system, transformed cells are visible 5-6 d after transduction. It takes 20-30 d before true iPSC colonies mature enough for colony expansion (Fig. 2c) . Overcrowded fibroblast cells often suppress the emergence of iPSC colonies, and thus EDTA dissociation could be used to differentially enrich iPSCs.
After mechanical isolation of iPSC colonies, EDTA dissociation enables effective expansion and cryopreservation in 1-2 weeks, markedly decreasing the time needed to preserve the cells. Owing to its simplicity, we are able to passage 24 individual lines from a 24-well plate in 15 min. 
